Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: FTSE +0.04%, DAX30 (0.11%), CAC40 (0.12%)

Sep 19 ,2023

  • Synopsis

    • European equity markets are set to open mixed amidst Asian equities mostly lower in a quiet Tuesday session. Nikkei underperforming region while Greater China markets have come off opening lows. S&P 500 futures flat afterhours. Oil prices extending recent gains; WTI currently above $91/bbl and Brent ~$95/bbl; Reuters notes weak shale output in the US spurred further concerns about a supply deficit stemming from extended production cuts by Saudi Arabia and Russia.

    • On today's agenda, German finance minister Christian Lindner speaking at Bloomberg Future of Finance conf. OECD to release Interim Economic Outlook. Elsewhere, Bafin and Bundesbank co-host BafinTech and German Aerospace Congress (both through Wed). Handelsblatt annual conference "Gas 2023" (through Wed) and Ukraine Defense Contact Group.

    • In central banks, BOE's Saporta speech at 9:15BST at Prudential Regulation Authority 'Conf, Truran speech at 10:15BST at BofA Financial CEO conf, BOE's Cleland panellist at 11:30BST at Sibos conf.

    • Macroeconomic releases due today include: Eurozone/Austria final Aug CPI, Portugal Aug PPI.

    • In Corporate news, Banco Santander (SAN.SM) announced the realignment of its operating model. The company is consolidating its retail & commercial and consumer activities across all markets under two new global businesses: Retail & Commercial and Digital Consumer Bank. In France, VINCI SA (DG.FP) and Aeroport de Paris (ADP.FP) both reported August traffic futures. Also in France, Afyren (ALAFY.FP), Actia Group (ALATI.FP) and SMCP (SMCP.FP) are among other companies from the region to update investors with their latest numbers. In Finland, Tietoevry (TIETO.FH) lowered its FY guidance and now expects organic growth of ~ 4% vs prior 5-7% and adjusted EBITA at 12.6-13.0% vs prior 13.0-13.5%.

    • In the UK, earnings/updates due from the likes of Kingfisher (KGF.LN), ASOS (ASC.LN), Hargreaves Lansdown (HL.LN), and Ocado (OCDO.LN).

  • Politics/Macro/World News

    • ECB to Keep Interest Rates at 4% as Long as Needed, Villeroy Says - Bloomberg

    • Meloni May Win €3 Billion Fiscal Room as Italy Ups 2021 GDP - Bloomberg

    • China and EU hold talks on AI, cross-border data flow amid renewed tensions - Reuters

    • German carmakers in the line of fire of possible EU-China trade war - FT

    • EU bridles at Keir Starmer's plan to seek 'much better' Brexit deal - The Times

  • Top company news

    • Earnings/updates

      • SAN.SM (Banco Santander) -- announces realigned operating model

      • DG.FP (VINCI SA) -- Vinci reports Aug Autoroutes and Airport passenger traffic

      • ADP.FP (Aeroport de Paris) -- reports August traffic 33.98M, +13.6% y/y

      • TIETO.FH (Tietoevry) -- lowers FY guidance; expects organic growth of ~ 4% vs prior 5-7% and adjusted EBITA at 12.6-13.0% vs prior 13.0-13.5%

      • SMCP.FP (SMCP) -- adjusts FY23 guidance: now expects adjusted EBIT margin between 7% and 9% vs prior guidance to improve its adjusted EBIT margin

      • VAR.NO (Vår Energi) -- narrows FY23 production guidance range to 210-220 kboepd, while maintaining FY25 production target of above 350 kboepd -- portfolio and operational update

      • ADOC.FP (Adocia) -- reports H1 net income (€9.4M) vs year-ago €4.3M

      • ABCA.FP (ABC arbitrage) -- reports H1 net income €8.8M, (46%) vs year-ago €16.2M

      • ALATI.FP (Actia Group) -- reports H1 net income €1.4M vs year-ago (€8.1M)

      • ALAFY.FP (Afyren) -- reports H1 revenue €1.96B, +11% vs year-ago €1.76B

      • Also reporting today

        • Earnings:

          • Benelux: Onward Medical (ONWD.BB)

          • France: Visiativ (ALVIV.FP), Latecoere (LAT.FP)

          • UK: Kingfisher (KGF.LN), Hargreaves Lansdown (HL.LN), Renishaw (RSW.LN), Serica Energy (SQZ.LN), Team17 Group (TM17.LN), Trustpilot (TRST.LN), Henry Boot (BOOT.LN), Eagle Eye Solutions (EYE.LN), Xaar (XAR.LN), DP Eurasia (DPEU.LN), McBride (MCB.LN), Water Intelligence (WATR.LN), Naked Wines (WINE.LN)

        • Trading Update: Ocado (OCDO.LN), C&C Group (CCR.LN), ASOS (ASC.LN), SThree (STEM.LN)

        • CMD/events: Anheuser-Busch InBev (ABI.BB) day 1 (of two) 16:00CET, British Land Co (BLND.LN) - retail parks, AstraZeneca (AZN.LN), ORIOR (ORON.SW), Zalaris (ZAL.NO), Futura Medical (FUM.LN), VNV Global (VNV.SS), Coloplast (COLO.B.DC), Serica Energy (SQZ.LN),

    • M&A

      • ACS.SM (ACS SA) -- announces acquisition of remaining 21% of Blueridge Transportation Group for $410.7M

      • FRE.GR (Fresenius) -- puts Curalie up for sale - Handelsblatt (18-Sep, 15:15 CET)

      • HO.FP (Thales) -- updates on discussions with European Union competition authority on sale of Thales' Ground Transportation Systems business to Hitachi Rail

      • HO.FP (Thales) -- Hitachi offers to sell assets in France and Germany in bid to address EU antitrust concerns over proposed acquisition of Thales' GTS business - Reuters

      • MTW.LN (Mattioli Woods) -- Mattioli Woods' subsidiary Ludlow Wealth Management Group Limited has acquired 100% of share capital of Opus Wealth Management Limited for initial consideration of £0.71M and potential further consideration of up to £0.71M

      • NACON.FP (Nacon) -- announces issuance of new shares in connection with acquisition of Big Ant Studios

    • Healthcare

      • SOBI.SS (Swedish Orphan Biovitrum) -- announces preliminary outcome of SEK 6.02B rights issue

      • PHXM.FP (Phaxiam Therapeutics) -- launches new preclinical development targeting a strong antimicrobial-resistant bacteria, Klebsiella pneumonia

      • AB.FP (AB Science) -- provides an update on the EMA timetable for examination of the masitinib marketing authorization application in ALS

      • ALBPS.FP (Biophytis) -- receives response from the French HAS to its request for Early Access Authorization in France for patients suffering from severe forms of COVID-19 and provides an update on its strategy in other countries.

    • Other

      • BA.LN (BAE Systems) -- awarded $67.0M US Navy contract modification

      • STERV.FH (Stora Enso) -- announces CEO Bresky to leave role; appoints Hans Sohlström as new CEO as of today

      • ETL.FP (Eutelsat Communications) -- announces new share repurchase program

      • CO.FP (Casino Guichard-Perrachon) -- Groupe Casino updates on negotiations with note holders issued by Quatrim; request to extend the conciliation proceedings

      • PGS.NO (PGS ASA) -- announces 45.8M share private placement priced at NOK 9.60 per share

      • TGS.NO (TGS-NOPEC Geophysical Co.) -- TGS and PGS complete private placements, raising NOK953.1M at NOK152.5/share and NOK439.3M at NOK9.60/share respectively

      • Rio Tinto believes Chinese steel consumption is close to maxing out - Bloomberg

  • Key rating changes

    • Upgrades

      • G.IM (Assicurazioni Generali) -- Assicurazioni Generali Insurer Financial Strength (IFS) upgraded to A+ from A at Fitch

      • PGS.NO (PGS ASA) -- to hold from sell at DnB Markets

      • VOW3.GR (Volkswagen) -- to buy from underperform at Jefferies

    • Downgrades

      • ELUX.B.SS (Electrolux) -- Electrolux short-term recommendation downgraded to hold from buy at Handelsbanken

      • NWG.LN (NatWest Group) -- to hold from buy at HSBC

      • TGS.NO (TGS-NOPEC Geophysical Co.) -- to hold from buy at DnB Markets

      • SFOR.LN (S4 Capital) -- to equal weight from overweight at Barclays

      • PAL.AV (Palfinger) -- to hold from buy at Kepler Cheuvreux

      • ALD.FP (ALD) -- to neutral from outperform at BNP Paribas Exane

      • GLE.FP (Societe Generale) -- to neutral from outperform at BNP Paribas Exane

      • HBH.GR (Hornbach Holding) -- to hold from buy at Kepler Cheuvreux

      • ETTE.FH (Etteplan) -- to hold from buy at Carnegie Securities

      • FDR.SM (Fluidra) -- to neutral from outperform at Oddo

    • Initiations

      • NOS.PL (NOS SGPS) -- buy at Societe Generale

      • TSCO.LN (Tesco plc) -- hold at Kepler Cheuvreux

    • Other Actions

      • COLO.B.DC (Coloplast) -- reinstated underweight at JPMorgan; prior rating was underweight

  • Data

    • Nikkei (1.10%) to 33162.96

    • Hang Seng (0.24%) to 17886.83

    • Shanghai Composite (0.19%) to 3120.04

    • S&P futures (3.0) vs prior close of 4501.5

    • €-$ (0.0012) or (0.11%) to 1.0680

    • $-¥ +0.19 or +0.13% to 147.80

    • €-¥ (0.01) or (0.01%) to 157.82

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE